Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

• Autores: M. Humbert, R. Beasley, J. Ayres
• Localización: The pharmacological basis of asthma and allergy: a collection of seminal articles / coord. por Juan Manuel Igea, 2017, ISBN 978-84-947204-0-6, págs. 425-434
• Idioma: inglés
• Texto completo no disponible (Saber más ...)